Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| New GGP, Inc. | 38,478,639 | reported | 08 Apr 2016 | tx 11−264,940 |
| Jefferies Credit Partners BDC Inc. | 17,435,119.1 | reported | 21 Jan 2025 | tx 3+3,470,723.59 |
| Overland Advantage | 11,615,772.8 | reported | 02 May 2025 | tx 1+1,226,521.44 |
| AGL Private Credit Income Fund LP | 10,059,535.53 | reported | 27 Mar 2025 | tx 2+3,982,598.27 |
| Senior Credit Investments, LLC | 146,633.625 | reported | 05 May 2026 | tx 3+33,188.493 |
| Foghorn Therapeutics Inc. | 0 | reported | 27 Oct 2020 | tx 3+1,231,081−2,000,001 |
| Hyatt Hotels Corp | 0 | reported | 14 Mar 2012 | tx 5+24,300−4,781,500 |
| Vir Biotechnology, Inc. | 0 | reported | 16 Oct 2019 | tx 5+3,666,666−2,666,666 |
| ConforMIS Inc | 0 | reported | 07 Jul 2015 | tx 3+3,125,000−6,250,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 May 2026 | PURCHASE | Senior Credit Investments, LLC | 16,876.813 | 1777.59 USD | first after silence |
| 02 May 2025 | PURCHASE | Overland Advantage | 1,226,521.44 | 24.74 USD | |
| 27 Mar 2025 | PURCHASE | AGL Private Credit Income Fund LP | 1,332,421.35 | 25.11 USD | |
| 21 Jan 2025 | PURCHASE | Jefferies Credit Partners BDC Inc. | 1,713,597.53 | 14.59 USD | |
| 30 Dec 2024 | PURCHASE | AGL Private Credit Income Fund LP | 2,650,176.92 | 25.19 USD | |
| 21 Oct 2024 | PURCHASE | Senior Credit Investments, LLC | 2,693.85 | 1856.08 USD | |
| 02 Feb 2024 | OTHER | Jefferies Credit Partners BDC Inc. | 264,690 | — | |
| 23 Jan 2024 | PURCHASE | Senior Credit Investments, LLC | 13,617.83 | 1835.83 USD | |
| 23 Jan 2024 | PURCHASE | Jefferies Credit Partners BDC Inc. | 1,492,436.06 | 14.74 USD | first after silence |
| 27 Oct 2020 | CONVERSION | Foghorn Therapeutics Inc. | 1,081,081 | — | |
| 27 Oct 2020 | PURCHASE | Foghorn Therapeutics Inc. | 150,000 | 16.00 USD | first after silenceanomaly |
| 27 Oct 2020 | CONVERSION | Foghorn Therapeutics Inc. | 2,000,001 | — | deriv |
| 16 Oct 2019 | CONVERSION | Vir Biotechnology, Inc. | 1,333,333 | — | |
| 16 Oct 2019 | PURCHASE | Vir Biotechnology, Inc. | 1,000,000 | 20.00 USD | first after silence |
| 16 Oct 2019 | CONVERSION | Vir Biotechnology, Inc. | 1,333,333 | — | |
| 16 Oct 2019 | CONVERSION | Vir Biotechnology, Inc. | 1,333,333 | 0.00 USD | deriv |
| 16 Oct 2019 | CONVERSION | Vir Biotechnology, Inc. | 1,333,333 | 0.00 USD | deriv |
| 07 Apr 2016 | SALE | New GGP, Inc. | 600 | 28.77 USD | |
| 08 Apr 2016 | SALE | New GGP, Inc. | 336 | 28.87 USD | |
| 06 Apr 2016 | SALE | New GGP, Inc. | 900 | 28.96 USD | |
| 05 Apr 2016 | SALE | New GGP, Inc. | 21,500 | 29.08 USD | |
| 18 Dec 2015 | SALE | New GGP, Inc. | 6,051 | 26.22 USD | |
| 16 Dec 2015 | SALE | New GGP, Inc. | 59,463 | 26.71 USD | |
| 30 Nov 2015 | SALE | New GGP, Inc. | 42,489 | 25.82 USD | |
| 11 Nov 2015 | SALE | New GGP, Inc. | 67,049 | 26.75 USD |
4 purchases reported after at least 12 months of silence — most recent on 05 May 2026.